Qiagen N.V. (QGEN) Social Stream
QIAGEN NV (QGEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering QGEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-10 | 6 | $60 | $47.5 | $55.005 | $44.93 | 22.42% |
| 2021-12-14 | 7 | $60 | $47.5 | $55.718 | $44.93 | 24.01% |
| 2022-02-09 | 7 | $60 | $47.5 | $55.005 | $44.93 | 22.42% |
| 2022-02-10 | 7 | $62 | $47.5 | $56.004 | $44.93 | 24.65% |
| 2022-04-04 | 7 | $62.001 | $47.5 | $56.004 | $44.93 | 24.65% |
| 2022-04-28 | 7 | $62.001 | $47.5 | $55.147 | $44.93 | 22.74% |
| 2022-05-02 | 7 | $60 | $47.5 | $53.861 | $44.93 | 19.88% |
| 2022-07-19 | 6 | $60 | $51 | $56 | $44.93 | 24.64% |
| 2022-07-29 | 7 | $60 | $51 | $56 | $44.93 | 24.64% |
| 2022-10-17 | 6 | $60 | $42.5 | $54.416 | $44.93 | 21.11% |
| 2022-10-18 | 5 | $60 | $42.5 | $54.416 | $44.93 | 21.11% |
| 2022-11-09 | 7 | $60 | $42.5 | $54.416 | $44.93 | 21.11% |
| 2022-11-10 | 8 | $60 | $42.5 | $53.785 | $44.93 | 19.71% |
| 2023-02-08 | 7 | $55 | $42.5 | $52.75 | $44.93 | 17.4% |
| 2023-02-10 | 8 | $60 | $42.5 | $53.357 | $44.93 | 18.76% |
| 2023-02-22 | 8 | $60 | $42.5 | $54.071 | $44.93 | 20.34% |
| 2023-05-08 | 9 | $62 | $42.5 | $55.062 | $44.93 | 22.55% |
| 2023-06-21 | 9 | $62 | $42.5 | $54.187 | $44.93 | 20.6% |
| 2023-07-26 | 9 | $62 | $42.5 | $54.062 | $44.93 | 20.32% |
| 2023-08-08 | 9 | $62 | $50 | $55.714 | $44.93 | 24% |
| 2023-08-09 | 9 | $62 | $50 | $55.857 | $44.93 | 24.32% |
| 2023-08-11 | 10 | $62 | $48 | $54.5 | $44.93 | 21.3% |
| 2023-09-13 | 10 | $60 | $48 | $53.75 | $44.93 | 19.63% |
| 2023-10-02 | 11 | $60 | $48 | $53.7 | $44.93 | 19.52% |
| 2023-10-03 | 11 | $60 | $48 | $53.333 | $44.93 | 18.7% |
| 2023-10-18 | 11 | $60 | $48 | $53.8 | $44.93 | 19.74% |
| 2023-10-20 | 11 | $60 | $46 | $52.7 | $44.93 | 17.29% |
| 2023-11-01 | 11 | $60 | $46 | $52.2 | $44.93 | 16.18% |
| 2023-11-03 | 11 | $60 | $44 | $50.1 | $44.93 | 11.51% |
| 2023-12-06 | 11 | $60 | $42 | $49 | $44.93 | 9.06% |
| 2023-12-12 | 12 | $60 | $42 | $49.09 | $44.93 | 9.26% |
| 2023-12-20 | 12 | $60 | $42 | $49.818 | $44.93 | 10.88% |
| 2023-12-26 | 12 | $60 | $42 | $50.272 | $44.93 | 11.89% |
| 2023-12-29 | 13 | $60 | $42 | $49.75 | $44.93 | 10.73% |
The Trend in the Analyst Price Target
Over the past 16 months, QGEN's average price target has gone down $4.67.
QGEN reports an average of 24.58% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-16 | 10 | 60 | 48 | 53.75 | 43.21 | 24.39% |
| 2023-09-01 | 10 | 60 | 48 | 53.75 | 44.61 | 20.49% |
| 2023-09-08 | 10 | 60 | 48 | 53.75 | 41.57 | 29.3% |
| 2023-10-06 | 11 | 60 | 48 | 53.80 | 40.51 | 32.81% |
| 2023-11-01 | 11 | 60 | 46 | 52.20 | 37.87 | 37.84% |
QGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.08 | 6 | 0 | 7 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 31 weeks, QGEN's average broker recommendation rating improved by 0.11.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of Pharmaceutical Products stocks, QIAGEN NV's variance in analysts' estimates is lower than -472.04% of them.
- In the context of stocks in the large market cap category, QIAGEN NV's number of analysts covering the stock is higher than 807.91% of them.
- In terms of how QIAGEN NV fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 923.5% of that group.
- In terms of how QIAGEN NV fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 2708.22% of that group.
Stocks similar to QIAGEN NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IDXX, QDEL, and GMAB.
View All Top Stocks by Price Target
Is QGEN a Buy, Hold or Sell? See the POWR Ratings now!